市場調查報告書
商品編碼
1215585
全球持續性腎臟替代治療 (CRRT) 市場:2022-2028 年Continuous Renal Replacement Therapy (CRRT) Market 2022-2028 |
在預測期內,全球連續性腎臟替代療法 (CRRT) 市場規模預計將以約 5.8% 的複合年增長率增長。
敗血症發病率上升和 AKI 患病率上升等因素正在推動市場增長。 通過模式,連續靜脈血液濾過(CVVH)部分預計在預測期內增長最快。 按地區劃分,預計亞太地區將佔據很大份額。 該地區的增長歸因於政府努力提高中國和印度等經濟體對腎臟治療的認識。
本報告調查了全球連續性腎臟替代療法 (CRRT) 市場,提供了市場概況、對市場增長的各種影響因素的分析、市場規模、各個細分市場、地區和主要國家的趨勢和預測。它總結了一個單獨的細分、競爭格局、主要參與者的概況等。
Title:Global Continuous Renal Replacement Therapy (CRRT) Market Size, Share & Trends Analysis Report by Product (Dialysates and Replacement Fluids and Disposables), by Modality (Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodiafiltration (CVVHDF), Continuous Venovenous Hemodialysis (CVVHD), Slow Continuous Ultrafiltration (SCUF)), and by Age-Group (Adults and Pediatrics /Neonates) Forecast Period (2022-2028).
The global CRRT market is projected to grow at a modest CAGR of nearly 5.8% during the forecast period. The key aspect that drives the growth of the market includes the rising prevalence of AKI coupled with the increased incidence of sepsis. For an instance, in an article published by the International Society of Nephrology 2020, countries such as China and India reported an AKI rate of 29% in 2019.
The global CRRT market is segmented based on product, modality, and age-group. Based on product, the market is segmented as dialysates and replacement fluids, and disposables. The disposables segment further includes hemofilter, bloodline sets and tubes, and other disposables. Based on modality, the market is segmented into continuous venovenous hemofiltration (CVVH), continuous venovenous hemodiafiltration (CVVHDF), continuous venovenous hemodialysis (CVVHD), and slow continuous ultrafiltration (SCUF). Among the modality, the Continuous Venovenous Hemofiltration (CVVH) segment is expected to be the fastest-growing segment during the forecast period. Based on age group, the market is segmented as adults, and pediatrics /neonates.
Geographically, the global CRRT market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. The Asia-Pacific region is projected to hold a significant market share. China, India, Japan, and the Rest of the Asia-Pacific are the major economies primarily contributing to the growth of the continuous renal replacement therapy market in the region. The regional growth of the market is accredited to government initiatives to spread awareness of renal therapy in the economies such as China and India. North America held a major market position in the global continuous renal replacement therapy market.
Further, Medtronic plc, Baxter International Inc., and Fresenius Medical Care AG & CO. KGaA among others are some of the prominent players operating in the market. Strategic initiatives along with competitive pricing may support an increase in the market share of the players during the forecast period. Manufacturers are extensively investing in new technologies. Moreover, new launches & developments, partnerships, collaborations, and mergers and acquisitions are some of the growth strategies adopted by the players to sustain in the highly competitive market. For an instance, in 2019, Fresenius Medical Care AG & CO. KGaA announced the launch of the 4008A dialysis machine in India.
Research Methodology
The market study of the global continuous renal replacement therapy (CRRT) market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
Secondary Sources Include:
The report is intended for continuous renal replacement therapy (CRRT) companies, manufacturing companies, retail companies, healthcare companies, government organizations, transportation, and logistics companies, software companies, research institutes and universities, other related companies, and government organizations for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.
Market Segmentation:
Global Continuous Renal Replacement Therapy (CRRT) Market Research and Analysis by Product.
Global Continuous Renal Replacement Therapy (CRRT) Market Research and Analysis by Modality.
Global Continuous Renal Replacement Therapy (CRRT) Market Research and Analysis by Age-Group.
The Report Covers: